• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE Back to Search Results
Model Number JF-260V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pancreatitis (4481)
Event Date 10/29/2022
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus.The investigation is in process.A supplemental report will be submitted upon completion of the investigation or if additional information is received.The literature is attached for additional information.
 
Event Description
Olympus reviewed the following literature titled "the usefulness of peroral cholangioscopy for intrahepatic stones." literature summary: this single-center retrospective study examined the results of transpapillary treatment of intrahepatic stones.A total of 26 patients were included.Complete stone removal (csr) was achieved in 92% (24/26) of cases; csr was not achieved in two cases.One case was an intrahepatic stone found incidentally and judged unnecessary to treat.The other case was after a bile duct resection for congenital biliary dilatation, and the double-balloon endoscope could not reach the anastomosis site.The median procedure time for the first session was 97 (27¿220) minutes, whereas that of the ehl under pocs group was 121 (43¿213) minutes and that of the fluoroscopic guidance group was 77 (27¿220) minutes, indicating that the ehl under pocs group had a significantly longer procedure time (p = 0.0195, mann¿whitney u test).In conclusion, endoscopic treatment for intrahepatic stones should be performed at established centers, because specialized devices such as a cholangioscope may be required and cholangitis may increase.Cholangitis developed in six (24%) and pancreatitis in three (12%) cases after the first session; however, all cases were mild and could be treated conservatively including antibiotic treatment.Although the incidence of cholangitis was high, there were no differences in complication rates between patients with and without ehl under pocs (p = 1, chi square test).Type of adverse events/number of patients: pancreatitis - 3 patients; cholangitis - 6 patients.This literature article requires 4 reports.The related patient identifiers are as follows: (b)(6): tjf-q290v duodenovideoscope; (b)(6): jf-260v duodenovideoscope; (b)(6): cf-hq290zi colonovideoscope; (b)(6): pr-110q-1 catheter.This medical device report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.This supplemental report includes additional information received from the author.B5 updated accordingly.Also, a correction was made to g2 to provide information that was inadvertently not included in the initial medwatch.Olympus will continue to monitor field performance for this device.
 
Event Description
The following information was received from the author: the adverse events described in the article were not caused by an olympus device.Also, there were no reports of an olympus device malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key17481484
MDR Text Key320662477
Report Number9610595-2023-11327
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberJF-260V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/10/2023
Initial Date FDA Received08/08/2023
Supplement Dates Manufacturer Received09/14/2023
Supplement Dates FDA Received09/22/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
CF-HQ290ZI COLONOVIDEOSCOPE; PR-110Q-1 CATHETER
Patient Outcome(s) Required Intervention;
-
-